Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia

Clinical and Laboratory Haematology

Volumn 28, Issue 1, 2006, Pages 30-35

  Saka, B ^a   Aktan, M ^a   Sami, U ^a   Oner, D ^a   Sanem, O ^a   Dincol G ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

CD23 antigen; Chronic lymphocytic leukemia; Prognosis

Indexed keywords

CD23 ANTIGEN; CD38 ANTIGEN; PROTEIN KINASE ZAP 70;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; BLOOD LEVEL; BONE MARROW; CANCER INFILTRATION; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; MALE; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD38; BONE MARROW NEOPLASMS; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECEPTORS, IGE; TUMOR MARKERS, BIOLOGICAL; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 33645067149     PISSN: 01419854     EISSN: 13652257     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2006.00750.x     Document Type: Article

References (20)

1. Binet J.L. Leporrier M. Dighiero G. Charron D. D'Athis P. Vaughier G. Beral H.M. Natall J.C. Raphael M. Nizet B. Follezou J.Y. 1977 A clinical staging system for chronic lymphocytic leukemia: prognostic significance Cancer 40 855 864
2. Damle R.N. Wasil T. Fais F. Ghiotto F. Valetto A. Allen S.L. Buchbinder A. Budman D. Dittmar K. Kolitz J. Lichtman S.M. Schulman P. Vinciguerra V.P. Rai K.R. Ferrarini M. Chiorazzi N. 1999 IgV gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia Blood 94 1840 1847
3. Dhodapkar M. Tefferi A. Su J. Phyliky R.L. 1993 Prognostic features and survival in young adults early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study Leukemia 7 1232 1235
4. 2+-dependent carbohydrate recognition domains in animal proteins Current Opinion in Structural Biology 3 393 400
5. Fournier S. Yang L.P. Delespesse G. Rubio M. Biron G. Sarfati M. 1995 The two CD23 isoforms display differential regulation in chronic lymphocytic leukemia British Journal of Haematology 89 373 379
6. Ibrahim S. Keating M. Do K.A. O'Brien S. Huh Y.O. Jilani I. Lerner S. Kantarjian H.M. Albitar M. 2001 CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia Blood 98 181 186
7. Molica S. 1997 Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters? Haematologica 82 705 709
8. Molica S. Alberti A. 1986 Prognostic value of the lymphocytic doubling time in chronic lymphocytic leukemia: analysis of its prognostic significance British Journal of Haematology 62 567 575
9. Molica S. Levato D. Dell'Olio M. Matera R. Minervini M. Dattilo A. Carotenuto M. Musto P. 1996 Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis Haematologica 81 428 433
10. Molica S. Levato D. Cascavilla N. Levato L. Musto P. 1999 Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta 2-microglobulin in B-cell chronic lymphocytic leukemia European Journal of Haematology 62 117 122
11. Montserrat E. Villamor N. Reverter J.C. Brugues R.M. Tassies D. Bosch F. Aguilar L. Vives-Corrons J.J. Rozman M. Rozma C. 1996 Bone marrow assessment in B cell chronic lymphocytic leukemia: aspirate or biopsy? A comparative study in 258 patients British Journal of Haematology 93 111 116
12. Mossalayi D. Dalloul A. Arock M. Debre P. 1992 Effect of CD23 on purified human hematopoietic cells Bone Marrow Transplantation 9 50 53
13. Rai K.R. Montserrat E. 1987 Prognostic factors in chronic lymphocytic leukemia Seminars in Hematology 24 252 256
14. Reinisch W. Willheim M. Hilgart M. Gasche C. Mader R. Szepfalusi S. Steger G. Berger R. Lechner K. Boltz-Nitulescu G. 1994 Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia Journal of Clinical Oncology 12 2146 2152
15. Rozman C. Montserrat E. Rodriguez-Fernandez J.M. Ayats R. Vallespi T. Parody R. Rios A. Prados D. Morey M. Gomis F. Alcala A. Gutirrez M. Maldonado J. Gonzalez C. Giralt M. Hernandez-Nieto L. Cabrera A. Fernandez-Ranada J.M. 1984 Bone marrow histologic pattern - the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases Blood 64 642 648
16. Sarfati M. Chevret S. Chastang C. Biron G. Stryckmans P. Delespesse G. Binet J.L. Helene Merle-Beral H. Bron D. 1996 Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia Blood 88 4259 4264
17. Schwarzmeier J.D. Shehata M. Hilgarth M. Marschitz I. Louda N. Hubmann R. Greil R. 2002 The role of soluble CD23 in distinguishing stable and progressive forms of B-chronic lymphocytic leukemia Leukemia and Lymphoma 43 549 554
18. White L.J. Ozanne B.W. Graber P. Aubry J.P. Bonnefoy J.Y. Cushley W. 1997 Inhibition of apoptosis in a human pre-B cell line by CD23 is mediated via a novel receptor Blood 90 234 243
19. Yokota A. Kikutani H. Tanaka T. Sato R. Barsumian E.L. Suemura M. Kishimoto T. 1988 Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression Cell 55 611 618
20. Yoshikawa T. Nanba T. Kato H. Hori K. Inamoto T. Kumagai S. Yodoi J. 1994 Soluble Fc epsilon RII/CD23 in patients with autoimmune diseases and Epstein-Barr virus-related disorders: analysis by ELISA for soluble Fc epsilon RII/CD23 Immunomethods 4 65 71